NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
GeneFerm Biotechnology Co. Ltd (TWO: 1796)
1796 Technical Analysis
5
As on 9th Jun 2023 1796 SHARE Price closed @ 114.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 47.15 & Strong Buy for SHORT-TERM with Stoploss of 43.73 we also expect STOCK to react on Following IMPORTANT LEVELS. |
1796SHARE Price
Open | 126.50 | Change | Price | % |
High | 128.50 | 1 Day | -12.50 | -9.88 |
Low | 114.00 | 1 Week | -17.00 | -12.98 |
Close | 114.00 | 1 Month | -4.50 | -3.80 |
Volume | 1353540 | 1 Year | 75.00 | 192.31 |
52 Week High 152.00 | 52 Week Low 38.00 |
TWO Taiwan Most Active Stocks
6125 | 44.70 | 5.67% |
4533 | 18.00 | 9.76% |
4979 | 76.40 | 9.93% |
6122 | 44.45 | 9.89% |
5425 | 102.00 | 9.09% |
8358 | 63.30 | 4.11% |
3374 | 128.00 | 9.87% |
2743 | 162.50 | -7.93% |
8069 | 227.00 | 5.09% |
1815 | 13.95 | 6.08% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
1796 Daily Charts |
1796 Intraday Charts |
Whats New @ Bazaartrend |
1796 Free Analysis |
|
1796 Important Levels Intraday
RESISTANCE | 141.94 |
RESISTANCE | 132.98 |
RESISTANCE | 127.44 |
RESISTANCE | 121.90 |
SUPPORT | 106.10 |
SUPPORT | 100.56 |
SUPPORT | 95.02 |
SUPPORT | 86.06 |
1796 Forecast April 2024
4th UP Forecast | 124.21 |
3rd UP Forecast | 120.94 |
2nd UP Forecast | 118.91 |
1st UP Forecast | 116.89 |
1st DOWN Forecast | 111.11 |
2nd DOWN Forecast | 109.09 |
3rd DOWN Forecast | 107.06 |
4th DOWN Forecast | 103.79 |
1796 Weekly Forecast
4th UP Forecast | 125.95 |
3rd UP Forecast | 122.12 |
2nd UP Forecast | 119.75 |
1st UP Forecast | 117.38 |
1st DOWN Forecast | 110.62 |
2nd DOWN Forecast | 108.25 |
3rd DOWN Forecast | 105.88 |
4th DOWN Forecast | 102.05 |
1796 Forecast2024
4th UP Forecast | 344.28 |
3rd UP Forecast | 270.43 |
2nd UP Forecast | 224.78 |
1st UP Forecast | 179.13 |
1st DOWN Forecast | 48.87 |
2nd DOWN Forecast | 3.22 |
3rd DOWN Forecast | -42.43 |
4th DOWN Forecast | -116.28 |
GeneFerm Biotechnology Co. Ltd ( TWO Taiwan Symbol : 1796 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
1796 Other Details
Segment | EQ | |
Market Capital | 1523469056.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
1796 Address
1796 Latest News
1796 Business Profile
GeneFerm Biotechnology Co., Ltd. develops, manufactures, markets, and sells fermented products in Taiwan and internationally. The company offers a range of raw materials, such as fermented microbial, fungi, and fruits and vegetables products; probiotics; and herbal extracts and animal derived peptides and powders. It also provides ODM, as well as fermentation toll manufacturing services to companies for the development and manufacture of dietary supplements, functional foods, health food products, and various applications. The company was founded in 1999 and is based in Taipei City, Taiwan. Address: Nangang Software Park, Taipei City, Taiwan, 11503
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service